Cogent Biosciences, Inc.
USD39.08
+1.14 (+3.00%)
CEO
Andrew R. Robbins
IPO Date
2018-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$37.34
Prev. Close
$37.94
Day Low
$37.07
Day High
$39.39
52W Low
$10.38
52W High
$43.73
Market Cap
$6.68B
Volume
1.91M
| 17,901 |
| $31.98 |
| 11 Jun 2026 | Ferrante Karen Jean | director | A-Award | Acquired | 17,901 | $31.98 |
| 11 Jun 2026 | CAIN CHRISTOPHER W. | director | A-Award | Acquired | 17,901 | $31.98 |
| 11 Jun 2026 | Shegog Todd | director | A-Award | Acquired | 17,901 | $31.98 |
| 11 Jun 2026 | Morris Arlene | director | A-Award | Acquired | 17,901 | $31.98 |
| 11 Jun 2026 | Ros Matthew | director | A-Award | Acquired | 17,901 | $31.98 |
| 21 May 2026 | Robbins Andrew R | director, officer: President and CEO | G-Gift | Disposed | 160,000 | $0.00 |
| 21 May 2026 | Robbins Andrew R | director, officer: President and CEO | G-Gift | Acquired | 160,000 | $0.00 |
| 3 Apr 2026 | Ferrante Karen Jean | director | A-Award | Acquired | 686 | $35.24 |